Navigation Links
Can Blood Test Predict Breast Cancer Risk?
Date:5/1/2012

TUESDAY, May 1 (HealthDay News) -- A blood test that spots changes in a specific gene could reveal a woman's risk for breast cancer years before the disease has a chance to develop, researchers report.

British scientists analyzed blood samples from 640 breast cancer patients and 741 women without breast cancer. The samples from the breast cancer patients were collected an average of three years before they were diagnosed with the disease.

The objective was to find out if the alteration of single genes by a process called methylation could predict a woman's breast cancer risk.

The researchers found that women with the highest level of methylation on one area of a gene called ATM were two times more likely to develop cancer than those with the lowest level of methylation. Methylation is a critical process where chemicals known as "methyl groups" are added to DNA, to make sure everything is in good working order. High levels of methylation signal high levels of DNA trouble.

This result was particularly pronounced in blood samples taken from women under the age of 60, Dr. James Flanagan, a Breast Cancer Campaign scientific fellow in the department of surgery and cancer at Imperial College London, said in a news release from the Breast Cancer Campaign.

The study was published May 1 in the journal Cancer Research.

Unlike previous studies that took blood from breast cancer patients after diagnosis, these blood samples identified alterations in the ATM gene that did not occur because of having active cancer or cancer treatments.

The findings provide strong evidence that looking for this type of alteration in individual genes could be used as a blood test to help predict a woman's chances of developing breast cancer, the researchers said.

Used in combination with other breast cancer risk assessment tools such as genetic testing and risk factor profiling, this blood test could help identify women at higher risk. This early warning could be used to monitor these patients and one day perhaps even prevent them from developing breast cancer.

"We know that genetic variation contributes to a person's risk of disease. With this new study, we can now also say that epigenetic variation, or differences in how genes are modified, also has a role," Flanagan said.

"We hope that this research is just the beginning of our understanding about the epigenetic component of breast cancer risk, and in the coming years we hope to find many more examples of genes that contribute to a person's risk. The challenge will be how to incorporate all of this new information into the computer models that are currently used for individual risk prediction," he noted.

"So far, we have found alterations in one small region of a gene that appear to associate with risk of disease, and so the next step with this epigenetic research is a genome-wide approach to try and find all the associated genes," Flanagan explained.

More information

The American Cancer Society has more about breast cancer risk factors.

-- Robert Preidt

SOURCE: Breast Cancer Campaign, news release, May 1, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Blood Clot Risk for Outpatients Needs More Attention: Study
2. Stopping Blood Thinners Raises Stroke Risk for Patients With Irregular Heartbeat
3. Nano-devices that cross blood-brain barrier open door to treatment of cerebral palsy
4. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
5. Exercise May Help Patients With High Blood Pressure Live Longer
6. Diabetes Groups Issue New Guidelines on Blood Sugar
7. Naturopathic care can improve blood sugar, mood in diabetes
8. Researchers Develop Blood Test for Depression
9. Changes in gene expression may help explain high blood pressure in pregnancy
10. High Blood Pressure May Be Especially Lethal for Blacks
11. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Can Blood Test Predict Breast Cancer Risk?
(Date:5/24/2016)... ... May 24, 2016 , ... ... and safety labels , has been featured in the National Electrical ... The eiXtra e-newsletter provides electroindustry professionals with manufacturer, regulatory, and standardization news. The ...
(Date:5/24/2016)... ... 24, 2016 , ... After graduating from Cornell, author Joshua Alexander ... on medication, living on Social Security disability and staying in a group home. In ... It!” (published by Balboa Press), Alexander shares how he was finally able to heal ...
(Date:5/24/2016)... ... May 24, 2016 , ... Design Concepts , a ... del Quinto Sol Wheel Park’ in Pueblo, Colorado. This park was designed working ... special for this often overlooked neighborhood. Located at 609 E. 6th Street, Pueblo’s ...
(Date:5/24/2016)... ... 24, 2016 , ... NutraPre today announced the nationwide release ... to prevent morning sickness and promote overall heath. Engineered with advanced nanotechnology, this ... of water. , “Imagine a pregnancy without morning sickness,” NutraPre CEO Eddie Cameron ...
(Date:5/23/2016)... ... ... to an article published May 12th on the Medical Daily, as a great ... article points out that, as long as patients are brushing as they should – twice ... course, these worn-out bristles won’t clean teeth and gum tissue as effectively, so the article ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... Oregon , May 19, 2016 ... titled, World Medical/Diagnostic Imaging Market -Opportunities and Forecasts, 2015 ... reach $45.0 billion by 2022, registering a CAGR of ... expected to continue to be the highest revenue-generating segment ... accounted for around one-third of the market share ...
(Date:5/19/2016)... -- The equities market is never short of ... is without doubt the Healthcare space. ActiveWallSt.com has uncovered four ... Alkermes PLC (NASDAQ: ALKS ), AMAG Pharmaceuticals Inc. ... IDXX ), and Atossa Genetics Inc. (NASDAQ: ... http://www.activewallst.com/ On Wednesday, Alkermes PLC,s ...
(Date:5/19/2016)... 2016 MGB Biopharma, a ... Anti-infectives, Welcomes the Final Instalment of Lord Jim ...   Lord Jim O,Neill,s ... recommendations, providing a comprehensive action plan for the ... rising threat of superbugs - something that could ...
Breaking Medicine Technology: